VA Medical Center

The University of Kansas Cancer Center and Kansas City Veteran Medical Center have established a partnership to provide veterans with access to early-phase cancer clinical trials, addressing a critical gap in cancer care.

NRx Pharmaceuticals has filed the initial section of its New Drug Application (NDA) to the FDA for NRX-100 (ketamine) to treat suicidal depression.

A recent GAO report reveals that the Departments of Defense (DOD) and Veterans Affairs (VA) dedicated approximately $20 billion and $10 billion, respectively, to biomedical R&D from 2019 to 2023.